GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Total Payout Yield %

ME Therapeutics Holding (XCNQ:METX) Total Payout Yield % : 0.00 (As of Jun. 14, 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Total Payout Yield %?

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

ME Therapeutics Holding's current Total Payout Yield % is 0.00%.


ME Therapeutics Holding Total Payout Yield % Historical Data

The historical data trend for ME Therapeutics Holding's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Total Payout Yield % Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Total Payout Yield %
- -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Total Payout Yield % Get a 7-Day Free Trial - - - - -

Competitive Comparison of ME Therapeutics Holding's Total Payout Yield %

For the Biotechnology subindustry, ME Therapeutics Holding's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ME Therapeutics Holding's Total Payout Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's Total Payout Yield % falls into.



ME Therapeutics Holding Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

ME Therapeutics Holding's Total Payout Yield % for the fiscal year that ended in Aug. 2023 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- (0 + 0.116 + 0) / 0
=N/A%

ME Therapeutics Holding's annualized Total Payout Yield % for the quarter that ended in Feb. 2024 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- (0 + 0 + 0) * 4 / 103.9918
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ME Therapeutics Holding Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.


ME Therapeutics Holding Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding (XCNQ:METX) Business Description

Comparable Companies
Traded in Other Exchanges
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines